Page 53 - Read Online

Page 10 of 11 Cote et al. J Cancer Metastasis Treat 2022;8:36 https://dx.doi.org/10.20517/2394-4722.2022.41

apoptosis in thyroid cells. J Biol Chem 2000;275:18266-70. DOI PubMed
47. Wang YG, Li L, Liu CH, Hong S, Zhang MJ. Peroxiredoxin 3 is resistant to oxidation-induced apoptosis of Hep-3b cells. Clin Transl
Oncol 2014;16:561-6. DOI PubMed
48. Cox AG, Winterbourn CC, Hampton MB. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling.
Biochem J 2009;425:313-25. DOI PubMed
49. Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and
disease. Cell 2017;171:273-85. DOI PubMed PMC
50. Wu J, Minikes AM, Gao M, et al. Publisher correction: intercellular interaction dictates cancer cell ferroptosis via NF2-YAP
signalling. Nature 2019;572:E20. DOI PubMed
51. Fennell D. Cancer-cell death ironed out. Nature 2019;572:314-5. DOI PubMed
52. Zhang Y, Shi J, Liu X, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol 2018;20:1181-92.
DOI PubMed PMC
53. Bononi A, Yang H, Giorgi C, et al. Germline BAP1 mutations induce a Warburg effect. Cell Death Differ 2017;24:1694-704. DOI
PubMed PMC
54. Hebert L, Bellanger D, Guillas C, et al. Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial
function. Oncotarget 2017;8:72513-27. DOI PubMed PMC
55. Newick K, Cunniff B, Preston K, et al. Peroxiredoxin 3 is a redox-dependent target of thiostrepton in malignant mesothelioma cells.
PLoS One 2012;7:e39404. DOI PubMed PMC
56. Cunniff B, Benson K, Stumpff J, et al. Mitochondrial-targeted nitroxides disrupt mitochondrial architecture and inhibit expression of
peroxiredoxin 3 and FOXM1 in malignant mesothelioma cells. J Cell Physiol 2013;228:835-45. DOI PubMed PMC
57. Kong X, Li L, Li Z, et al. Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer. Cancer Res
2013;73:3987-96. DOI PubMed PMC
58. Schiavello M, Gazzano E, Bergandi L, et al. Identification of redox-sensitive transcription factors as markers of malignant pleural
mesothelioma. Cancers (Basel) 2021;13:1138. DOI PubMed PMC
59. Scalcon V, Bindoli A, Rigobello MP. Significance of the mitochondrial thioredoxin reductase in cancer cells: An update on role,
targets and inhibitors. Free Radic Biol Med 2018;127:62-79. DOI PubMed
60. Lu J, Holmgren A. The thioredoxin antioxidant system. Free Radic Biol Med 2014;66:75-87. DOI PubMed
61. Cunniff B, Snider GW, Fredette N, Hondal RJ, Heintz NH. A direct and continuous assay for the determination of thioredoxin
reductase activity in cell lysates. Anal Biochem 2013;443:34-40. DOI PubMed PMC
62. Schrepfer E, Scorrano L. Mitofusins, from Mitochondria to Metabolism. Mol Cell 2016;61:683-94. DOI PubMed
63. Lee JE, Westrate LM, Wu H, Page C, Voeltz GK. Multiple dynamin family members collaborate to drive mitochondrial division.
Nature 2016;540:139-43. DOI PubMed PMC
64. Eura Y, Ishihara N, Yokota S, Mihara K. Two mitofusin proteins, mammalian homologues of FZO, with distinct functions are both
required for mitochondrial fusion. J Biochem 2003;134:333-44. DOI PubMed
65. Ježek J, Cooper KF, Strich R. The Impact of mitochondrial fission-stimulated ROS Production on pro-apoptotic chemotherapy.
Biology (Basel) 2021;10:33. DOI PubMed PMC
66. Ježek J, Cooper KF, Strich R. Reactive Oxygen species and mitochondrial dynamics: the yin and yang of mitochondrial dysfunction
and cancer progression. Antioxidants (Basel) 2018;7:13. DOI PubMed PMC
67. Han XJ, Yang ZJ, Jiang LP, et al. Mitochondrial dynamics regulates hypoxia-induced migration and antineoplastic activity of
cisplatin in breast cancer cells. Int J Oncol 2015;46:691-700. DOI PubMed
68. Wan YY, Zhang JF, Yang ZJ, et al. Involvement of Drp1 in hypoxia-induced migration of human glioblastoma U251 cells. Oncol
Rep 2014;32:619-26. DOI PubMed
69. Latimer HR, Veal EA. Peroxiredoxins in regulation of MAPK signalling pathways; sensors and barriers to signal transduction. Mol
Cells 2016;39:40-5. DOI PubMed PMC
70. Ko SH, Choi GE, Oh JY, et al. Author correction: succinate promotes stem cell migration through the GPR91-dependent regulation
of DRP1-mediated mitochondrial fission. Sci Rep 2018;8:13326. DOI PubMed PMC
71. Aravamudan B, Kiel A, Freeman M, et al. Cigarette smoke-induced mitochondrial fragmentation and dysfunction in human airway
smooth muscle. Am J Physiol Lung Cell Mol Physiol 2014;306:L840-54. DOI PubMed PMC
72. Jung JU, Ravi S, Lee DW, et al. NIK/MAP3K14 regulates mitochondrial dynamics and trafficking to promote cell invasion. Curr
Biol 2016;26:3288-302. DOI PubMed PMC
73. Liu TL, Upadhyayula S, Milkie DE, et al. Observing the cell in its native state: Imaging subcellular dynamics in multicellular
organisms. Science 2018;360:eaaq1392. DOI PubMed PMC
74. Iwahori K, Serada S, Fujimoto M, et al. SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical
antitumor activity against malignant pleural mesothelioma. Int J Cancer 2013;132:459-71. DOI PubMed
75. Nishikawa S, Tanaka A, Matsuda A, et al. A molecular targeting against nuclear factor-κB, as a chemotherapeutic approach for
human malignant mesothelioma. Cancer Med 2014;3:416-25. DOI PubMed PMC
76. Goparaju CM, Blasberg JD, Volinia S, et al. Onconase mediated NFKβ downregulation in malignant pleural mesothelioma.
Oncogene 2011;30:2767-77. DOI PubMed PMC
77. Lennon FE, Cianci GC, Kanteti R, et al. Unique fractal evaluation and therapeutic implications of mitochondrial morphology in